FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Blaine Labs Revitaderm Wound Care Recall

Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0

Blaine Labs Inc · Santa Fe Springs, CA

Risk level
Class II
Reported by FDA
Jul 8, 2026
Recall ID
D-0699-2026
Check your lot numberHow we source this data

Summary

Blaine Labs recalled Revitaderm Wound Care starting Apr 8, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0699-2026 on Jul 8, 2026. Reason: CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated. Status: Ongoing.

Why it was recalled

CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated

Product description

Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,

Lot numbers, UPCs & expiration codes

Lots: (a) 1 oz - BL3435, Exp 11/06/26; BL3525, Exp 08/07/27. (b) 3 oz- Lots # BL3435, 11/06/26 & BL3525, 08/07/27

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0699-2026
Classification
Class II
Status
Ongoing
Recall initiated
Apr 8, 2026
FDA report date
Jul 8, 2026
Quantity
5,555 bottles and tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Blaine Labs Inc

Original FDA data

Every field from FDA enforcement report D-0699-2026, exactly as published.

Show all FDA fields
City
Santa Fe Springs
State
CA
Status
Ongoing
Country
United States
Event ID
98731
Address
11037 Lockport Pl
Code information
Lots: (a) 1 oz - BL3435, Exp 11/06/26; BL3525, Exp 08/07/27. (b) 3 oz- Lots # BL3435, 11/06/26 & BL3525, 08/07/27
Postal code
90670-4634
Report date
Jul 8, 2026
Product type
Drugs
Recall number
D-0699-2026
Classification
Class II
Recalling firm
Blaine Labs Inc
Product quantity
5,555 bottles and tubes
Reason for recall
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
Voluntary / mandated
Voluntary: Firm initiated
Product description
Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 8, 2026
Initial firm notification
Press Release
Center classification date
Jul 16, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0699-2026, published Jul 8, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls